Blood sugar tightrope: can intensive control help stem cell patients?
NCT ID NCT00582036
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether keeping blood sugar very tightly controlled (goal of 110 mg/dL) using continuous insulin could help people undergoing stem cell transplants. The researchers wanted to see if it would lower death rates, reduce infections, and shorten hospital stays. However, the trial was stopped early and only included 11 participants, so we cannot draw strong conclusions from it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Regular insulin
What this could lead to
If it worked, this approach could reduce infections and shorten hospital stays for stem cell transplant patients.
What could go wrong
The trial was terminated early and enrolled only 11 people, so results are very limited. Tight glucose control can also cause dangerously low blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States